Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: data from the BEVORDEX randomised clinical trial

Mehta Hemal; Fraser-Bell Samantha; Yeung Aaron; Campain Anna; Lim Lyndell L.; Quin Godfrey J.; McAllister Ian L.; Keane Pearse A.; Gillies Mark C.

首页> 外文期刊>British journal of ophthalmology >Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: data from the BEVORDEX randomised clinical trial

【24h】

Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: data from the BEVORDEX randomised clinical trial

机译：地塞米松和贝伐单抗对糖尿病性黄斑病中硬性渗出物消退的功效：来自BEVORDEX随机临床试验的数据

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective To report the effect of bevacizumab versus dexamethasone on hard exudates (HEX) in diabetic macular oedema (DME).

机译：目的报道贝伐单抗与地塞米松对糖尿病性黄斑水肿（DME）中硬性渗出物（HEX）的影响。

著录项

来源
《British journal of ophthalmology》 |2016年第7期|共5页
作者
Mehta Hemal; Fraser-Bell Samantha; Yeung Aaron; Campain Anna; Lim Lyndell L.; Quin Godfrey J.; McAllister Ian L.; Keane Pearse A.; Gillies Mark C.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词

相似文献

外文文献
中文文献
专利

1. Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: data from the BEVORDEX randomised clinical trial [J] . Mehta Hemal, Fraser-Bell Samantha, Yeung Aaron, British journal of ophthalmology . 2016,第7期

机译：地塞米松和贝伐单抗对糖尿病性黄斑病中硬性渗出物消退的功效：来自BEVORDEX随机临床试验的数据
2. Short-term vision gains at 12 weeks correlate with long-term vision gains at 2 years: results from the BEVORDEX randomised clinical trial of bevacizumab versus dexamethasone implants for diabetic macular oedema [J] . Mehta Hemal, Fraser-Bell Samantha, Vuong Nguyen, British journal of ophthalmology . 2018,第4期

机译：12周内的短期视觉增益与2年的长期视觉增益相关：Bevordex随机临床试验的结果对贝伐单抗与糖尿病性黄斑水肿的地塞米松植入物
3. Short-term vision gains at 12 weeks correlate with long-term vision gains at 2 years: results from the BEVORDEX randomised clinical trial of bevacizumab versus dexamethasone implants for diabetic macular oedema [J] . Mehta Hemal, Fraser-Bell Samantha, Vuong Nguyen, British journal of ophthalmology . 2018,第4期

机译：12周内的短期视觉增益与2年的长期视觉增益相关：Bevordex随机临床试验的结果对贝伐单抗与糖尿病性黄斑水肿的地塞米松植入物
4. A Framework for Patient Data Management and Analysis in Randomised Clinical Trials [C] . Pietro Hiram Guzzi, Tiziana Larussa, Rosarina Vallelunga, IEEE International Conference on Bioinformatics and Biomedicine . 2020

机译：随机临床试验中患者数据管理和分析的框架
5. Analysis of data from a clinical trial comparing different drug treatments for dyspepsia using binomial regression and binary classification trees [D] . Rose, Caren 2004

机译：使用二项式回归和二叉分类树比较一项针对消化不良的不同药物治疗的临床试验数据进行的分析
6. Quantitative evaluation of hard exudates in diabetic macular edema after short-term intravitreal triamcinolone dexamethasone implant or bevacizumab injections [O] . Yong Un Shin, Eun Hee Hong, Han Woong Lim, 2017

机译：短期玻璃体内曲安奈德地塞米松植入或贝伐单抗注射后糖尿病黄斑水肿中硬性渗出液的定量评估
7. Vision-Related Quality of Life Outcomes in the BEVORDEX Study: A Clinical Trial Comparing Ozurdex Sustained Release Dexamethasone Intravitreal Implant and Bevacizumab Treatment for Diabetic Macular Edema [O] . Christine Aroney, Samantha Fraser-Bell, Ecosse L. Lamoureux, 2016

机译：Bevordex研究中的视觉相关质量结果：临床试验，比较Ozurdex持续释放地塞米松玻璃体植入物和Bevacizumab治疗糖尿病黄斑水肿

Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: data from the BEVORDEX randomised clinical trial

摘要

著录项

相似文献

相关主题

期刊订阅